In this brochure, the EMCDDA's Scientific Director takes us on a journey through 25 years of annual reporting on the drugs problem in Europe.
The journey begins with the first report describing the drug situation in 1995 and leads us, over...
COVID-19
How is the COVID-19 pandemic affecting drug use, supply and services?
Drug use and harms
What are the health costs of drug use in Europe today?
Drug markets
What do the latest data tell us about drug...
According to the UN High Commissioner for Refugees (UNHCR) there are now close to 80 million forcibly displaced people worldwide, and with mental health among this segment of the world’s population already a neglected area, the treatment...
This webinar explored how regulations put in place to prevent the spread of COVID-19 are inadvertently contributing to an increasingly toxic illegal drug supply and how this shift has both increased health harms and created policy...
The present issue of the Bulletin (vol. LXII, 2019), whose guest editor is Isidore Obot, professor of Psychology, University of Uyo, and Director of the Centre for Research and Information on Substance Abuse, Uyo, Nigeria, is focused on the...
National and international drug prevention networks, community leaders and strong community coalitions are the key to changing public attitudes and reducing the availability of illicit drugs worldwide. Some effective tactics include...
Discussions on the decriminalization of drug possession for personal consumption are increasing, including an extraordinary appeal still pending judgment in the Supreme Court on this subject (RExt. 635.659).
However, it is frightening to...
